Modified Rheumatoid Arthritis Protocol for Rituximab in Pemphigus: A Retrospective Case Series

Background: Rituximab, an anticluster of differentation 20 antibody, has been shown in open series studies to be effective in treating pemphigus. In the literature, lymphoma (dose of 375mg/m(2), four-week infusion) and rheumatoid arthritis (two infusions of 1,000mg each, 15 days apart) are two proto...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Aesthet Dermatol
Autori principali: Sakhiya, Jagdish, Sakhiya, Dhruv, Khambhati, Ravi, Patel, Mehul, Darji, Piyush, Gajjar, Trusha, Daruwala, Feral, Dudhatra, Nimish
Natura: Artigo
Lingua:Inglês
Pubblicazione: Matrix Medical Communications 2020
Soggetti:
Case Series
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7158908/
https://ncbi.nlm.nih.gov/pubmed/32308784
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi